Copyright © 2003 by the European Society of Cardiology.
The use of hospital admission data as a measure of outcome in clinical studies of heart failure
a Medical Research Council Biostatistics Unit, Institute of Public Health, Cambridge, UK
b Department of Cardiac Medicine, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, UK
Received May 20, 2003; accepted June 22, 2003 * Correspondence: Chris Metcalfe, Research Associate, MRCBiostatistics Unit, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 2SR, U.K
Aim To describe and evaluate the methods currently used to summarize, depict, and analyse hospitalization data in clinical studies of patients with heart failure.
Methods and Results Studies published during 1999 and 2000 were reviewed if they reported hospitalization data collected during the follow-up of a defined group of adults who had been diagnosed as having heart failure. Of 130 studies identified, the majority considered only the first of any hospital admissions for each individual. When presented, statistical analyses in 70% of papers, and graphics in 75% of papers, were based purely on the first hospitalization. A minority of papers based analyses on the number of admissions (23%), or the amount of time spent in hospital by patients (14%) during the follow-up period.
Conclusions Data on the hospitalizations undergone by patients with heart failure are potentially informative about the disease burden to individuals and health services. The widespread practice of focussing a statistical analysis on the first admission a patient undergoes discards those aspects of hospitalization that are informative about disease burden: multiple admissions and length of stay. Statistical methods that incorporate these aspects appeared in a handful of papers, and the more widespread adoption of these is desirable.
Key Words: Heart failure hospitalization mortality disease burden statistical methods systematic review
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- How should we analyse hospitalizations in clinical trials?
- K. Dickstein and S. Snapinn
EHJ 2003 24: 24-25.[Extract] [Full Text]
This article has been cited by other articles:
![]() |
C. Metcalfe and S. G. Thompson Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: should it be applied to a recurrent events outcome? Statistical Methods in Medical Research, April 1, 2007; 16(2): 103 - 122. [Abstract] [PDF] |
||||
![]() |
H. Skali, M. A. Pfeffer, J. Lubsen, and S. D. Solomon Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials Circulation, November 21, 2006; 114(21): 2298 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murray-Thomas and M. R Cowie Epidemiology and clinical aspects of congestive heart failure Journal of Renin-Angiotensin-Aldosterone System, September 1, 2003; 4(3): 131 - 136. [Abstract] [PDF] |
||||


